Development of anti-metastatic and tumour targeting reagents by design of inhibitors to specific Eph/ephrin cell-cell

  • Lackmann, Martin (Primary Chief Investigator (PCI))
  • Boyd, Andrew Wallace (Chief Investigator (CI))
  • Scott, Andrew (Chief Investigator (CI))
  • Treutlein, Herbert (Chief Investigator (CI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/07/03 → 30/06/04

Funding

  • National Health and Medical Research Council (NHMRC) (Australia): A$200,000.00